Innovating treatment for patients who suffer from allergic reactions including anaphylaxis.
Our mission is to develop treatments for patients and parents affected by severe allergic reactions that are safe and effective, needle-free, easy to carry, simple to administer and help eliminate the anxiety and hesitation associated with using an injectable device.
Innovating treatment for patients who suffer from allergic reactions including anaphylaxis.
Our mission is to develop treatments for patients and parents affected by severe allergic reactions that are safe and effective, needle-free, easy to carry, simple to administer and help eliminate the anxiety and hesitation associated with using an injectable device.
Rethinking Epinephrine Therapy
ARS is currently developing a needle-free nasal spray designed to consistently deliver a pharmacodynamic exposure of epinephrine that is similar to existing treatments. Our nasal spray may help reduce hesitation and allow patients to confidently administer when needed.
Patient and Caregiver preparedness to act quickly and confidently during a severe allergic reaction is imperative. Hesitation can lead to worse clinical outcomes and can be fatal. ARS is committed to transforming the way we think about and use life-saving epinephrine.
ARS recognizes that there are multiple pitfalls in treatments for severe allergic reaction, which include:
Fear of needles and anxiety about injecting oneself or a loved one
Needle-related injuries (e.g. lacerations, blood vessel injections)
Device bulkiness and portability
Miscomprehension and complexity of proper administration
Misconception of when to use, resulting in hesitation